SCHEMBL25538870

SCHEMBL25538870

CC(C)CC(c1ccc([C@H](C)N)cc1)N1CC2(CN(C(=O)OC(C)(C)C)C2)C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ RORC P51449 1/20 0.36
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ GPR119 Q8TDV5 1/20 0.35
▸ PARP1 P09874 1/20 0.35
▸ ATM Q13315 2/20 0.34
▸ JAK2 O60674 2/20 0.33
▸ JAK1 P23458 2/20 0.33
▸ GPR183 P32249 1/20 0.33
▸ CYP11B2 P19099 1/20 0.33
▸ CTSS P25774 1/20 0.33
▸ CTSK P43235 1/20 0.33
▸ DPP4 P27487 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25538864 0.90 HTT (0.38) HTTMAPTNPC1ALDH1A1MAPK1
SCHEMBL25538923 0.87 ATM (0.36) HTTMAPTNPC1ALDH1A1MAPK1
SCHEMBL25538861 0.86 NPC1 (0.40) HTTMAPTNPC1ALDH1A1MAPK1
SCHEMBL25538971 0.86 HTT (0.35) HTTMAPTNPC1ALDH1A1MAPK1
SCHEMBL20289582 0.85 MAPT (0.46) HTTMAPTNPC1ALDH1A1MAPK1
SCHEMBL25538977 0.84 HTT (0.36) HTTMAPTNPC1ALDH1A1MAPK1
SCHEMBL25543365 0.83 MEN1 (0.43) HTTMAPTNPC1ALDH1A1MAPK1
SCHEMBL21541346 0.80 RORC (0.50) HTTMAPTNPC1ALDH1A1MAPK1
SCHEMBL18459272 0.80 RORC (0.50) HTTMAPTNPC1ALDH1A1MAPK1
SCHEMBL31668187 0.79 HDAC2 (0.43) HTTMAPTNPC1ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174550-A1 IDH MUTANT INHIBITOR AND USE THEREOF Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2023-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174550-A1 IDH MUTANT INHIBITOR AND USE THEREOF IDH1, IDH3A, IDH3B HTT 267/4885MAPT 2754/4885NPC1 2367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback